DermYoung, Eden MedSpa launch campaign to help NYC first responders
May 27th 2020DermYoung and Eden MedSpa announce the launch of their “Together We Are Love, Together We Will Heal,” campaign which aims to provide NYC first responders with facials and take-home skincare kits for those experiencing skin damage and irritation due to PPE usage.
Trifarotene cream proves safe, effective for acne vulgaris
May 11th 2020A recent clinical review proves trifarotene 0.005% cream is an effective and safe treatment for acne vulgaris on the face and neck in patients 9 years and older. Currently, the drug is one of four topical retinoid acne treatments available on the market.
FDA approves efinaconazole for onychomycosis in patients 6 years and older
April 30th 2020Ortho Dermatologics announces the U.S. FDA supplemental New Drug Application approval for efinaconazole 10% (JUBLIA) for the treatment of onychomycosis, a fungal toenail infection, in patients 6 years and older.
The Mainstream Patient: April 28
April 28th 2020In this week's edition of The Mainstream Patient, we share some stories aboout milia and blackhead treatment, what exercising with the wrong face mask can do to your skin, why you shouldn't resort to cutting off your skin tags during the pandemic and why you should avoid giving yourself a stick and poke tattoo.
Menlo and Cutia enter agreement for topical minocycline products
April 24th 2020Menlo Therapeutics announces its wholly-owned subsidiary Foamix Pharmaceuticals Ltd. is entering a licensing with Cutia Therapeutics for the company’s FDA-approved 4% topical minocycline foam (AMZEEQ, Foamix) for acne vulgaris in pediatric and adult patients.
Patient enrollment completed for Dermavant phase 3 psoriasis clinical trials
April 22nd 2020Dermavant announces the enrollment completion for their two phase 3 clinical trials investigating the topical therapeutic aryl hydrocarbon receptor (TAMA) tapinarof as a treatment for adult plaque psoriasis, with results from the study still expected in the second half of 2020 despite the current pandemic.